Tag Archives: Zofran bleeding

Questions about Zofran bleeding and compensation? Speak to one of our Zofran lawyers today during a free consultation.

Grant & Eisenhofer’s Beth Graham to Speak on Zofran (ondansetron) Litigation

At the April 2016 Mass Torts Made Perfect conference in Las Vegas later this month, Grant & Eisenhofer Director Elizabeth Graham, co-lead on the Plaintiffs’ Executive Committee of the Zofran (ondansetron) multi-district litigation, will speak to the latest developments in the litigation. Ms. Graham will cover the status of the over 230 cases centralized...

Read more

Louisiana Family Files Zofran (ondansetron) Lawsuit over Heart Defects

In one of the latest complaints filed against GlaxoSmithKline LLC over the anti-nausea drug Zofran (ondansetron), a family from Louisiana claims that the drug caused their two children to be born with heart defects. Zofran (ondansetron) was first approved by the FDA in 1991 for use in cancer patients undergoing chemotherapy or radiation therapy...

Read more

Alabama Couple Speaks Out Publicly Against Dangers of Zofran (ondansetron)

In February 2016, an Alabama couple spoke out openly about the hardships anti-nausea drug Zofran (ondansetron) has caused their family. During her pregnancy, Clara Rickman took a generic version of Zofran, ondansetron, which she claims led to her child being born with multiple congenital heart defects. The Rickmans say their son has undergone three...

Read more

Plaintiffs Oppose GlaxoSmithKline’s Motion to Dismiss Failure to Warn Claims

With already more than 200 complaints pending in the Zofran (ondansetron) federal multidistrict litigation (“MDL”) in the District of Massachusetts, the drug’s manufacturer GlaxoSmithKline (“GSK”) is asking U.S. District Judge Dennis Saylor to dismiss the plaintiffs’ failure-to-warn claims, arguing there is evidence that the FDA would have rejected any warning label update the plaintiffs...

Read more

Real Time Analytics